In vivo results indicate that the nanoparticles can efficiently accumulate at tumor tissues, suppress tumor growth, and reshape immunosuppressive tumor microenvironment through mTOR inhibition‐enhanced PDT, angiogenesis inhibition, and anti‐cancer immune activation. The gene discussed is MTOR; the disease is neoplasm.